Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
941678-49-5
Purity
95%
Ruxolitinib is an antineoplastic agent that inhibits cell proliferation, induces apoptosis of malignant cells, and reduces pro-inflammatory cytokine plasma levels by inhibiting JAK-induced phosphorylation of signal transducer and activator of transcription (STAT). It is used to treat various types of myelofibrosis, polycythemia vera.
Properties
Name
Ruxolitinib
Smiles
N#CC[C@H](C1CCCC1)N2C=C(C=N2)C=3N=CN=C4NC=CC34
Targets
Please log in to see this information
SDS
(R)-ruxolitinib | INCB018424 | Rux | jakafi | ruxolitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$72
2 mg
$76
5 mg
$81
10 mg
$107
15 mg
$131
20 mg
$156
25 mg
$169
30 mg
$186
35 mg
$204
40 mg
$222
45 mg
$236
50 mg
$257
75 mg
$388
100 mg
$POA
Quantity
1
Total amount
$ 81
(R)-ruxolitinib | INCB018424 | Rux | jakafi | ruxolitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.